Duloxetine Capsule, Delayed Release
Product Images NDC 60760-461

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 60760-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dulox (Duloxetine 60760 461 30)

NDC 60760-461-30 is a medication sold in capsule form to treat various ailments. Each capsule contains 30mg of Duloxdme Delayed Release. The medication is packaged in four different capsule types. It is also available in various quantities: QTY 30, QTY 30, QTY 30, and QTY 20. Each capsule type has a unique RX#, LOT#, and EXP date. This medication must be stored in a controlled room environment at a temperature between 15°- 30° C (59°-86°F). The medication must be used as directed by a healthcare professional. The product has been packaged by "nep 4 St. Mary's art 3 10550 MAVINEE DR,QRO VALLEY, A7 85737."*

FDA Label Image

Figure01 (Duloxetine Fig01)

FDA Label Image

Figure2 (Duloxetine Fig02)

The text describes a graph showing the proportion of patients with relapse over time after randomization to a treatment (Placebo or Duloxetine). The graph has axes labeled "Proportion of Patients with Relapse" and "Time from Randomization to Relapse (Days)" and shows data points for both treatments. The x-axis ranges from 0 to 300 days and the y-axis ranges from 0 to 10% with increments of 2%.*

FDA Label Image

Figure04 (Duloxetine Fig04)

FDA Label Image

Figure07 (Duloxetine Fig07)

This is a chart showing the effectiveness of duloxetine in treating pain. The drug is administered once a day in doses of either 60 or 120 mg. The chart measures the percentage of pain improvement from baseline after taking the drug. There are no other details available.*

FDA Label Image

Figure08 (Duloxetine Fig08)

The text provides numerical data on a pain management treatment study. The study compared a Placebo treatment to a regimen of Duloxetine taken once daily at 60mg. The results are presented visually in a chart that displays a percentage of the improvement in pain from the baseline for patients in the study. The chart shows values ranging from 0 to 100 with increments of 10. There is also a line graph that shows the improvement in pain for Duloxetine treatment ranging from 210 to 100. There is no additional information regarding the study's methodology, sample size or demographics.*

FDA Label Image

Figure09 (Duloxetine Fig09)

This is a description of a placebo study involving Duloxetine. The dosage for the drug is either 60 or 120 mg and taken once a day. The text also includes a table with numeric values related to pain improvement from baseline.*

FDA Label Image

Duloxetine-structure (Duloxetine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.